Hill Medical
Corporation

Where to
Find us

We are proud to offer state-of-the-art diagnostic imaging services in Pasadena and Glendora, California, and surrounding counties.


My-Radiologist.com

What exactly is a radiologist?

The Hill Medical Corporation is a proud participant in the My-Radiologist.com national consumer awareness campaign.

My-Radiologist.com was created by a national consortium of independent, sub-specialized radiology practices, including The Hill Medical Corporation, that have aligned efforts to educate healthcare consumers regarding the scope of services provided by radiologists, as well as the importance of seeking out a sub-specialized radiology group. Through this unified voice, these radiology groups have created a platform to effectively educate consumers about the importance of connecting with the right radiologist for their healthcare needs. The campaign directs patients to talk to their physicians to get the most informed opinion in choosing the right imaging center and the right radiology group.

What exactly is a Radiologist? The answer may surprise you. Learn more about the role your radiologist plays in your healthcare at My-Radiologist.com.




What You Need To Know About Lung Cancer

Click document to download

GADOLINIUM CONTRAST AGENTS & YOUR MRI

The U.S. Food and Drug Administration (FDA) is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (MRI) concerning gadolinium remaining in patients' bodies, including the brain, for months to years after receiving the contrast. Gadolinium retention has not been directly linked to adverse health effects in patients with normal kidney function, and the FDA has concluded that the benefit of all approved GBCAs continues to outweigh any potential risks. Hill Medical continues to encourage research to better understand its clinical significance. In the meantime, the risk-benefit equation in most situations favors continued use of gadolinium-containing contrast agents for indicated examinations according to ACR guidelines. The FDA approved gadolinium-based contrast agents (GBCA) in 1988 and since then they have been used in more than 300 million patients worldwide to guide diagnosis and treatment, according to the American College of Radiology (ACR). ACR affirmed that gadolinium-based contrast agents "provide crucial, life-saving medical information."

How to Prepare for your MRI Exam
Patient Forms to Review Prior to your Exam
Frequently Asked Questions regarding Gadolinium Contrast

BREAST DENSITY LAW

Starting April 1, 2013, The Jim & Eleanor Randall Breast Center and The Hill Imaging Center, Inc. are mandated by the State of California to notify patients via written form if on their screening mammography their breast density tissue was categorized either heterogeneously dense or extremely dense breasts. These categories are based on the Breast Imaging Reporting and Data System established by the American College of Radiology.
Breast Density Law


Web Design, SEO & Marketing by Idyllwild Advertising